Dear Forum, In my company we used to make training models in line with PDA Technical Report No. 35 (2001) A Proposed Training Model for the Microbiological Function in the Pharmaceutical Industry. It was a valuable resource. It is a retired document and the reason I found on the PDA website is that "it is no longer considered to represent current industry best practices". I am not keen to present content which reffers to the retired document, should I say outdated. Is there any other similar document which can aid us in the training program, what would you suggest? I for one liked this TR very much. Jovan Quality Operations Specialist Odricanje od odgovornosti: Ova poruka mo?e da sadr?i poverljive informacije i namenjena je samo licima kojima je upu?ena. Ova poruka mo?e biti distribuirana u okviru HEMOFARM AD Vr?ac ili povezanih lica u okviru STADA grupe u vezi sa poslovnim aktivnostima ovih dru?tava. Ukoliko ste gre?kom primili ovu elektronsku poruku, molim vas odmah obavestite po?iljaoca i izbri?ite istu sa va?eg ra?unara. Svako neovla??eno umno?avanje, ?irenje, kopiranje, obelodanjivanje, izmena, distribucija i/ili objavljivanje ove elektronske poruke je strogo zabranjeno. Sadr?aj ove elektronske poruke ne predstavlja nu?no stavove HEMOFARM A.D. Vr?ac ili povezanih lica u okviru STADA grupe. HEMOFARM A.D. Vr?ac mo?e obra?ivati va?e podatke o li?nosti u skladu sa va?e?im propisima. Obave?tenje o obradi podataka o li?nosti od strane HEMOFARM A.D. Vr?ac u skladu sa propisima mo?ete na?i na http://www.hemofarm.com/srb/obavestenje-o-obradi-podataka Disclaimer: This message may contain confidential data and should only be read by those persons to whom it is addressed. This message may be distributed within HEMOFARM A.D. Vr?ac or its affiliates within STADA group in relation with business activities of these entities. If you have received this E-mail message in error, please notify the sender immediately and delete the message from your computer. Any unauthorised form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this E-mail message is strictly prohibited. The contents of this e-mail do not necessarily represent the views of the HEMOFARM A.D. Vr?ac or affiliates within STADA group. HEMOFARM A.D. Vr?ac may process your personal data in line with existing laws. Notification on personal data processing by HEMOFARM A.D. Vr?ac in line with regulations can be accessed at http://www.hemofarm.com/eng/obavestenje-o-obradi-podataka ------------------ The PMFList is supported by our sponsors as a service to the scientific community. Please take a second to visit our sponsors' web sites and say thank you for their support of this service. If your company would be interested in sponsoring this community, please contact [log in to unmask] Steris - http://www.sterislifesciences.com/ Charles River Laboratories - https://www2.criver.com/l/60962/2020-03-27/h6jqv6 Veltek Associates, Inc - http://www.sterile.com Microbiologics, Inc. - http://www.microbiologics.com BD Industrial Media - http://www.bd.com/ds/ Associates of Cape Cod, Inc. - http://www.acciusa.com/ ================================= The nature of this service is to provide a medium for communication. The specific statements and endorsements of individuals participating in the discussions are not necessarily those of the PMF or the sponsors of the list.